Bone Tumors
8
0
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
Electrochemotherapy in Musculoskeletal Tumors
Biomechanics of Metastatic Defects in Bone
Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic Sarcomas
Application of Painting Analysis and Psychotherapy in Children With Bone Tumors
The Application of Personalized Titanium Plate in the Bone Tumors Around the Knee
Vascular CT Assessment of Structural Autograft and Allograft Healing
Bioactive Glass Granules in Filling of Bone Defects
Navigation Surgery for Bone and Soft Tissue Tumor